A new de novo mutation in the GCK gene causing MODY2

Diabetes Research and Clinical Practice

Volumn 93, Issue 1, 2011, Pages

  Cappelli, Alessia ^a   Silvestri, Serena ^b   Tumini, Stefano ^c   Carinci, Silvia ^c   Cipriano, Paola ^c   Massi, Luciano ^d   Staffolani, Paolo ^b   Pianese, Luigi ^b  

^a UNIVERSITY OF CAMERINO   (Italy)

^b UOC Laboratorio Analisi Cliniche e Microbiologiche   (Italy)

^c UNIVERSITY OF CHIETI   (Italy)

^d ASUR ZT 13   (Italy)

Author keywords

De novo mutation; GCK; MODY2

Indexed keywords

GLUCOKINASE; HEMOGLOBIN A1C; INSULIN;

ADOLESCENT; ARTICLE; CASE REPORT; CLINICAL FEATURE; FRAMESHIFT MUTATION; GENE; GENETIC ASSOCIATION; GLUCOKINASE GENE; HUMAN; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; MALE; MATURITY ONSET DIABETES MELLITUS; MUTATIONAL ANALYSIS; ONSET AGE; ORAL GLUCOSE TOLERANCE TEST;

ADOLESCENT; DIABETES MELLITUS, TYPE 2; GLUCOKINASE; HUMANS; MALE; MUTATION;

EID: 79960555681     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2011.04.006     Document Type: Article

References (10)

1. Matschinsky F., Liang Y., Kesavan P., Wang L., Froguel P., Velho G., et al. Glucokinase as pancreatic beta cell glucose sensor and diabetes gene. J Clin Invest 1993, 92:2092-2098.
2. Iynedjian P.B. Mammalian glucokinase its gene. Biochem J 1993, 293:1-13.
3. Gidh-Jain M., Takedat J., Xu L.Z., Lange A.J., Vionnett N., Stoffelt M., et al. Glucokinase mutations associated with non-insulin-dependent (type 2) diabetes mellitus have decreased enzymatic activity: implications for structure/function relationships. Proc Natl Acad Sci U S A 1993, 90:1932-1936.
4. Fajans S.S., Bell G.I., Polonsky K.S. Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N Engl J Med 2001, 27:971-980.
5. Stenson P.D., Mort M., Ball E.V., Howells K., Phillips A.D., Thomas N.S., et al. The Human Gene Mutation Database: 2008 update. Genome Med 2009, 1:13.
6. Osbak K.K., Colclough K., Saint-Martin C., Beer N.L., Bellanné-Chantelot C., Ellard S., et al. Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia. Hum Mutat 2009, 30:1512-1526.
7. Massa O., Meschi F., Cuesta-Munoz A., Caumo A., Cerutti F., Toni S., et al. High prevalence of glucokinase mutations in Italian children with MODY. Influence on glucose tolerance, first-phase insulin response, insulin sensitivity and BMI. Diabetologia 2001, 44:898-905.
8. Hager J., Blanché H., Sun F., Vaxillaire N.V., Poller W., Cohen D., et al. Six mutations in the glucokinase gene identified in MODY by using a nonradioactive sensitive screening technique. Diabetes 1994, 43:730-733.
9. Velho G., Blanche H., Vaxillaire M., Bellanne-Chantelot C., Pardini V.C., Timsit J., et al. Identification of 14 new glucokinase mutations and description of the clinical profile of 42 MODY-2 families. Diabetologia 1997, 40:217-224.
10. Cappelli A., Tumini S., Consoli A., Carinci S., Piersanti C., Ruggiero G., et al. Novel mutations in GCK and HNF1A genes in Italian families with MODY phenotype. Diabetes Res Clin Pract 2009, 83:72-74.